Advanced Therapy Medicinal Products - elearning for healthcare
Menu Access our elearning programmes on the elfh Hub Hub Register / Log in >
This programme is in partnership with...
  • Advanced Therapy Treatment Centres
  • Midlands and Wales Advanced Therapy Treatment Centre
  • Cell and Gene Therapy Catapult
  • London Advanced Therapies
  • NHS Blood and Transplant
  • Health Education England_New logo 2021
  • NHS Education for Scotland
  • Specialist Pharmacy Service
  • UK Research and Innovation
  • National Institute for Health Research

About the Advanced Therapy Medicinal Products programme

Advanced therapy medicinal products (ATMPs) are complex treatments requiring new ways of working, knowledge and skills for the many staff groups involved in their delivery to patients, as well as presenting urgent learning needs for the healthcare professionals who care for these patients, and for the professional development teams responsible for delivering education and training.

This series of elearning sessions is designed give the learner a basic understanding of advanced therapies, the steps involved in producing these medicines and how they function in the body. The sessions take the learner from the basics of cell and gene therapy and different modalities of treatment, through to a more in-depth look at products currently being delivered through both commissioned treatment and clinical trials. Learners will also be introduced to the unique challenges of bringing these pioneering treatments to patients, as they often present novel logistical and handling requirements.

The sessions each last approximately 30-45 minutes, covering the following topics:
  • Introduction to advanced therapy medicinal products
  • In vivo gene therapies
  • Immune effector cell therapy
  • Focus on CAR-T cell therapy
  • The logistics of ATMPs in hospitals
  • Advanced therapy investigational medicinal product (ATIMP) clinical trials
  • ISBT 128 labels for advanced therapies
  • Procurement of cells or tissues as starting ATMP materials
  • Safe use of low temperature transport vessels
  • T cell receptor therapy in solid tumours
  • Gene Therapy Medicinal Products, GMOs and Bio-containment
  • Patient and public involvement and engagement (PPIE) in advanced therapy medicinal products (ATMPs)

More information

Across the UK, there are four centres that are working to address the unique and complex challenges of bringing pioneering advanced therapy medicinal products (ATMPs) to patients. Together the centres aim to develop robust systems for the routine delivery of ATMPs as a standard of care throughout the NHS. Three of these centres make up the Advanced Therapy Treatment Centre (ATTC) network which is coordinated by the Cell and Gene Therapy Catapult and supported by the Industrial Strategy Challenge Fund, part of the government’s modern Industrial Strategy. The fund is delivered by UK Research and Innovation. These centres are:

  • Innovate Manchester Advanced Therapy Centre Hub (iMATCH)
  • Midlands-Wales Advanced Therapy Treatment Centre (MW-ATTC)
  • Northern Alliance Advanced Therapies Treatment Centre (NA-ATTC)

The London Advanced Therapies network is funded by Research England and brings together the London scientific community working in the field of cell and gene-based therapies.

The four centres are working together, along with the Cell and Gene Therapy Catapult, to specifically look at the training requirements for the current workforce and what needs to be put in place to support delivery of these novel treatments. Experience of delivering ATMPs is currently limited to a small number of specialist centres nationwide and there is a need for awareness-raising and knowledge-building across the wider NHS workforce.

For further information on the programmes, please see


  • A training resource (slides and short videos) to introduce considerations around thawing and visual inspection of cell therapy medicinal products.
    Download >
  • The ATMP webinar series
    This series of webinars will cover many aspects of cell and gene therapies, from the basics providing an introduction to how this new technology can modify diseases though to a more in-depth look into operational aspects of delivering advanced therapies.
  • Logistics animation
    A short animation to introduce the logistics supply chain for transporting advanced therapies, with a particular focus on cell- or tissue-based products.

  • Nitya’s patient story
    A short video giving an insight into one patient’s experience of receiving CAR T cell therapy.

Meet the team

  • Uta Griesenbach

    Uta Griesenbach

    Professor of Molecular Medicine at Imperial College London
  • Ceri Roberts

    Ceri Roberts

    Scientific Training Manager – Cellular and Molecular Therapies, NHS Blood and Transplant
  • Glenda Watson

    Glenda Watson

    Senior Teaching Fellow, Imperial College London
  • Michelle Davies

    Michelle Davies

    Interim Operational Lead, NIHR Manchester Clinical Research Facility, The Christie NHS Foundation Trust, Manchester
  • Maria Farrell

    Maria Farrell

    Senior Practice Facilitator for Advanced Cellular Therapies, The Christie NHS Foundation Trust
  • Sarah Hanson

    Sarah Hanson

    Senior Paediatric Research Nurse, Leeds General Infirmary
  • Kamilah Lakhani-Powell

    Kamilah Lakhani-Powell

    ATTC Business Programme Manager
  • Jonathan Guy

    Jon Guy

    Programme Manager, HEE elearning for healthcare
  • Dave Beardmore

    Dave Beardmore

    Project Manager, HEE elearning for healthcare
  • Angelina Montinaro

    Angelina Montinaro

    Lead Instructional Designer, HEE elearning for healthcare
  • Runam Prasad

    Runam Prasad

    Learning Designer, HEE elearning for healthcare
  • Rachel Grant

    Rachel Grant

    Learning Designer, HEE elearning for healthcare
  • Rashmi Chavda

    Rashmi Chavda

    Graphic Designer, HEE elearning for healthcare
  • Louise Garrahan

    Louise Garrahan

    Stakeholder Officer, HEE elearning for healthcare

How to access

In order to access the Advanced Therapy Medicinal Products programme, you will need an elfh account. If you do not have one, then you can register by selecting the Register button below.

Register >

To view the Advanced Therapy Medicinal Products programme, select the View button below. If you already have an account with elfh, you will also be able to login and enrol on the programme from the View button.

View >

Not an NHS organisation?

If you are not an NHS health or care organisation and therefore do not qualify for free access elfh Hub, you may be able to access the service by creating an OpenAthens account.

To check whether or not you qualify for free access via OpenAthens, you can view the eligibility criteria and register on the ‘OpenAthens’ portal.

Registering large numbers of users

If you are a HR, IT or Practice Manager and would like to register and enrol large numbers of staff within your organisation for access onto the Advanced Therapy Medicinal Products programme, please contact elfh directly.

Organisations wishing to use their own LMS

For HR departments wanting to know more about gaining access to courses using an existing Learning Management System please contact elfh directly to express interest.

More information

Please select the following link for more information on how to use the elfh Hub.

elfh is a NHS England programme in partnership with the NHS and professional bodies